Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression

RN Golden, CB Nemeroff, P McSorley… - Journal of Clinical …, 2002 - psychiatrist.com
Background: Antidepressant efficacy may be compromised by early discontinuation of
treatment secondary to common, treatment-emergent side effects, including nausea …

[HTML][HTML] A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?

J Davies, J Read - Addictive behaviors, 2019 - Elsevier
Introduction The UK's current National Institute for Health and Care Excellence and the
American Psychiatric Association's depression guidelines state that withdrawal reactions …

A double‐blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients

J De Wilde, R Spiers, C Mertens… - Acta Psychiatrica …, 1993 - Wiley Online Library
A randomized, double‐blind, parallel‐group, 6‐week study was undertaken to compare the
efficacy and tolerability of once or twice daily administration of the selective serotonin …

Antidepressant withdrawal symptoms—telephone calls to a national medication helpline

D Taylor, S Stewart, A Connolly - Journal of affective disorders, 2006 - Elsevier
AIMS AND METHOD: Withdrawal symptoms are associated with cessation of all
antidepressants but particularly paroxetine and venlafaxine. We aimed to examine rates of …

Addressing clinical challenges of antidepressant discontinuation

GA Fava, F Cosci - American Journal of Psychiatry, 2019 - Am Psychiatric Assoc
TO THE EDITOR: In the December 2018 issue of the Journal, Jha and colleagues (1) claim
that antidepressant withdrawal typically resolves spontaneously over 2–3 weeks. They offer …

[HTML][HTML] Switching and stopping antidepressants

N Keks, J Hope, S Keogh - Australian Prescriber, 2016 - ncbi.nlm.nih.gov
Switching and stopping antidepressants - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …

Potential adverse effects of discontinuing psychotropic drugs: part 2: antidepressant drugs

RH Howland - Journal of Psychosocial Nursing and Mental …, 2010 - journals.healio.com
Understanding the particular pharmacology of different antidepressant drugs can help
explain their adverse effects when they are discontinued. For all antidepressant drugs …

A comparison of paroxetine and placebo in depressed outpatients

GC Dunbar, JL Claghorn, A Kiev… - Acta Psychiatrica …, 1993 - Wiley Online Library
To compare the safety and efficacy of paroxetine (n= 167) and placebo (n= 169), data from 4
centres using the same protocol were pooled. A double‐blind parallel group design was …

Prescription of selective serotonin reuptake inhibitors 1990-2004

JG Bramness, AM Hausken, S Sakshaug… - Tidsskrift for den …, 2005 - europepmc.org
Background Antidepressant drugs are important in the treatment of major depression. The
use of antidepressants in general and more specifically selective serotonin reuptake …

Escitalopram versus venlafaxine XR in the treatment of depression

SA Montgomery, HF Andersen - International Clinical …, 2006 - journals.lww.com
This article reanalyses and reviews data from the two published randomized clinical trials
comparing escitalopram and venlafaxine XR in the treatment of patients with major …